(Q42228751)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24673264%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

title

Highly versatile immunostimulating nanocapsules for specific immune potentiation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24673264%20AND%20SRC:MED&resulttype=core&format=json

Mercedes Peleteiro Olmedo

12 March 2020

author

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24673264%20AND%20SRC:MED&resulttype=core&format=json

Jose V Gonzalez-Aramundiz

12 March 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24673264%20AND%20SRC:MED&resulttype=core&format=json

Africa González Fernández

12 March 2020

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24673264%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

María J. Alonso

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24673264%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

author name string

Sara Vicente

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24673264%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Belén Díaz-Freitas

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24673264%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Susana Martínez-Pulgarín

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24673264%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Jose I Neissa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24673264%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Jose M Escribano

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24673264%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

Alejandro Sanchez

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24673264%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

publication date

27 March 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24673264%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24673264%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24673264%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

issue

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24673264%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

page(s)

2273-2289

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24673264%20AND%20SRC:MED&resulttype=core&format=json

Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens

12 March 2020

cites work

1 reference

Vaccine delivery carriers: insights and future perspectives.

21 January 2018

1 reference

Particulate vaccines: on the quest for optimal delivery and immune response.

21 January 2018

1 reference

Squalene emulsions for parenteral vaccine and drug delivery

21 January 2018

1 reference

Insect larvae biofactories as a platform for influenza vaccine production

21 January 2018

1 reference

A polymer/oil based nanovaccine as a single-dose immunization approach

21 January 2018

1 reference

Development and validation of HPLC method for imiquimod determination in skin penetration studies

21 January 2018

1 reference

Co-delivery of viral proteins and a TLR7 agonist from polysaccharide nanocapsules: a needle-free vaccination strategy.

21 January 2018

1 reference

Hepatitis B surface antigen nanoparticles coated with chitosan and trimethyl chitosan: Impact of formulation on physicochemical and immunological characteristics

21 January 2018

1 reference

Pharmacokinetics and biodegradation mechanisms of a versatile carboxymethyl derivative of chitosan in rats: in vivo and in vitro evaluation

21 January 2018

1 reference

21 January 2018

1 reference

Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines

21 January 2018

1 reference

The mechanism of action of MF59 - an innately attractive adjuvant formulation

21 January 2018

1 reference

Linker-based bio-compatible microemulsions.

21 January 2018

1 reference

Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles

21 January 2018

1 reference

Efficient induction of immune responses through intradermal vaccination with N-trimethyl chitosan containing antigen formulations.

21 January 2018

1 reference

Nanocarriers for cytoplasmic delivery: cellular uptake and intracellular fate of chitosan and hyaluronic acid-coated chitosan nanoparticles in a phagocytic cell model.

21 January 2018

1 reference

Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats

21 January 2018

1 reference

Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model.

21 January 2018

1 reference

Imiquimod: mode of action

21 January 2018

1 reference

Metalloproteinase and cytokine production by THP-1 macrophages following exposure to chitosan-DNA nanoparticles

21 January 2018

1 reference

Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential

21 January 2018

1 reference

21 January 2018

1 reference

Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccine.

21 January 2018

1 reference

Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination

21 January 2018

1 reference

Chitosan nanoparticles act as an adjuvant to promote both Th1 and Th2 immune responses induced by ovalbumin in mice

21 January 2018

1 reference

Mucosal immunization with recombinant influenza hemagglutinin protein and poly gamma-glutamate/chitosan nanoparticles induces protection against highly pathogenic influenza A virus.

21 January 2018

1 reference